These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872 [Abstract] [Full Text] [Related]
5. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M. J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878 [Abstract] [Full Text] [Related]
6. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?]. Narita M, Kurihara T, Usami M, Honda M. Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646 [Abstract] [Full Text] [Related]
7. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP). Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M. Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640 [Abstract] [Full Text] [Related]
13. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography. Ishida Y, Nagata S, Uehara T, Yasumura Y, Fukuchi K, Miyatake K. J Cardiol; 2001 Mar; 37 Suppl 1():121-8. PubMed ID: 11433815 [Abstract] [Full Text] [Related]